Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Unaudited Financial Results For The Quarter Ended June 30, 2017.

 Dear Sir, In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Financial Results for the quarter ended 30th June, 2017 along with the Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the Company in its meeting held today i.e 11th August, 2017 at Mumbai.
11-08-2017
Bigul

Outcome Of Board Meeting Held On 11Th August, 2017

 This is to inform you that the Board of Directors at their meeting held on Friday, 11th August 2017 at 12.00 P.M at the registered office of the company, inter alia transacted the following business: 1. Considered and took on record the Unaudited Financial Results along with Limited Review Report for the Quarter ended 30th June, 2017. 2. Fixed the date, time and place for the 44th Annual General Meeting of the Company and approved...
11-08-2017
Bigul

Intimation Of Postponement Of Board Meeting

 With reference to the earlier intimation dated 27th July 2017, regarding the meeting of Board of Directors of the Company which was scheduled to be held on 4th August, 2017 to inter alia consider, approve and take on records Unaudited Financial Results of the company along with Limited Review Report for the quarter ended 30th June, 2017 and other matters with permission of chair....
31-07-2017
Bigul

Board Meeting On 04Th August, 2017

 Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Friday, 4th August, 2017 at the registered office of the Company at Mumbai, inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter ended 30th June, 2017...
27-07-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investments Pvt Ltd
20-07-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading & Investments Pvt Ltd
20-07-2017
Bigul

Shareholding for the Period Ended June 30, 2017

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
14-07-2017
Bigul

Statement Of Investor Complaint For The Quarter Ended 30Th June, 2017.

 Pursuant to the provisions of Regulation 13(3) (Listing Obligation and Disclosure Requirement) Regulations, 2015, enclosed herewith is the Investor Grievance Report of our company for the Quarter ended 30th June, 2017.
11-07-2017
Bigul

Updates

 Subject: WHO-Geneva Approval for Unit - 2. Dear Sir/Madam, Mangalam Drugs & Organics Ltd, one of the leading Active Pharmaceutical Ingredients (APIs) manufacturing company internationally is pleased to announce that the Company has recently received the final approval of WHO-Geneva for its Plant on Unit-2 situated at Plot No. 1203, 3rd Phase, G.I.D.C, Vapi-396195 .
25-05-2017
Bigul

Revised Format Of Financial Results For 31/03/2017

 Please find attached herewith the statement showing the Audited Financial Results for the quarter / year ended 31st March, 2017 along with Statement of Assets and Liabilities and Auditor's Report of the Statutory Auditors of the Company in the revised format, wherein, there are no changes or variations in the figures as compared to the Audited Financial Results submitted by the Company on 08th May, 2017. Kindly take the same in your records and inform all your constituents accordingly.
23-05-2017
Next Page
Close

Let's Open Free Demat Account